Autoantibodies against Endophilin A2 as a novel biomarker are beneficial to early diagnosis of breast cancer

Name: Autoantibodies against Endophilin A2 as a novel biomarker are beneficial to early diagnosis of breast cancer
Creator: xiaomeng Li
Published: 2023-09-15T05:41:18.992Z
Keywords: Enzyme-Linked Immunosorbent Assay

Li, xiaomeng

doi:10.17632/z47pry8gsw.2

Autoantibodies against Endophilin A2 as a novel biomarker are beneficial to early diagnosis of breast cancer

Published: 15 September 2023| Version 2 | DOI: 10.17632/z47pry8gsw.2

Contributor:

xiaomeng Li

Description

This document contains the relevant clinical information and EA2 antibody test results of all breast cancer patients.

Files

Institutions

Xi'an Jiaotong University

Autoantibodies against Endophilin A2 as a novel biomarker are beneficial to early diagnosis of breast cancer

Description

Files

Institutions

Categories

Licence